• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性恰加斯病患者的药物不良反应及其相关因素。

Adverse drug events and the associated factors in patients with chronic Chagas disease.

机构信息

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

出版信息

Rev Soc Bras Med Trop. 2020 Apr 22;53:e20190443. doi: 10.1590/0037-8682-0443-2019. eCollection 2020.

DOI:10.1590/0037-8682-0443-2019
PMID:32321092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7182287/
Abstract

INTRODUCTION

Herein, we aimed to identify the factors associated with adverse drug events (ADEs) in chronic Chagas disease (CD) patients.

METHODS

We analyzed 320 medical notes from 295 patients. The Naranjo algorithm was applied to determine the cause of ADEs. Mixed effects logistic regression was performed to evaluate the factors associated with ADEs.

RESULTS

ADEs were described in 102 medical notes (31.9%). Captopril was most frequently associated with ADEs. Age (RR 0.96; 95%CI 0.94-0.99) and cardiac C/D stages (RR 3.24; 95%CI 1.30-4.58) were the most important clinical factors associated with ADEs.

CONCLUSIONS

Close follow-up is warranted for CD patients.

摘要

简介

本研究旨在确定慢性恰加斯病(CD)患者发生药物不良事件(ADEs)的相关因素。

方法

我们分析了 295 名患者的 320 份病历。应用 Naranjo 算法确定 ADEs 的原因。采用混合效应逻辑回归评估与 ADEs 相关的因素。

结果

102 份病历(31.9%)描述了 ADEs。卡托普利与 ADEs 最相关。年龄(RR 0.96;95%CI 0.94-0.99)和心脏 C/D 期(RR 3.24;95%CI 1.30-4.58)是与 ADEs 最相关的重要临床因素。

结论

需要对 CD 患者进行密切随访。

相似文献

1
Adverse drug events and the associated factors in patients with chronic Chagas disease.慢性恰加斯病患者的药物不良反应及其相关因素。
Rev Soc Bras Med Trop. 2020 Apr 22;53:e20190443. doi: 10.1590/0037-8682-0443-2019. eCollection 2020.
2
Improved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural Bolivia.强化治疗方案在玻利维亚农村地区提高了对恰加斯病药物不良反应的完成率和特征描述。
PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2407. doi: 10.1371/journal.pntd.0002407. eCollection 2013.
3
Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.入院时预期寿命有限的晚期慢性病患者的药物不良事件。
Eur J Clin Pharmacol. 2017 Jan;73(1):79-89. doi: 10.1007/s00228-016-2136-8. Epub 2016 Oct 4.
4
Post-Marketing Safety Surveillance of the Salvia Miltiorrhiza Depside Salt for Infusion: A Real World Study.注射用丹参多酚酸盐上市后安全性监测:一项真实世界研究
PLoS One. 2017 Jan 26;12(1):e0170182. doi: 10.1371/journal.pone.0170182. eCollection 2017.
5
Risk factors for hospital admissions associated with adverse drug events.与药物不良事件相关的住院风险因素。
Pharmacotherapy. 2013 Aug;33(8):827-37. doi: 10.1002/phar.1287. Epub 2013 May 17.
6
Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.抗生素致住院患者不良药物反应和不良药物事件的因果关系和可预防评估:巴基斯坦拉合尔的一项多中心、横断面研究。
PLoS One. 2018 Jun 27;13(6):e0199456. doi: 10.1371/journal.pone.0199456. eCollection 2018.
7
Adverse drug events identified by triggers at a teaching hospital in Brazil.巴西一家教学医院通过触发因素识别出的药物不良事件。
BMC Pharmacol Toxicol. 2014 Dec 13;15:71. doi: 10.1186/2050-6511-15-71.
8
Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.成人人群中药物的标签外使用与药物不良事件的关联性。
JAMA Intern Med. 2016 Jan;176(1):55-63. doi: 10.1001/jamainternmed.2015.6058.
9
Adverse drug events in hospitalized patients with chronic kidney disease.慢性肾脏病住院患者的药物不良事件
Int J Clin Pharmacol Ther. 2010 Sep;48(9):571-6. doi: 10.5414/cpp48571.
10
The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.日本精神科住院患者药物不良事件和用药错误的流行病学:JADE研究
BMC Psychiatry. 2016 Aug 30;16(1):303. doi: 10.1186/s12888-016-1009-0.

引用本文的文献

1
Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care.恰加斯心脏病:诊断、表现、治疗及护理概述
World J Cardiol. 2021 Dec 26;13(12):654-675. doi: 10.4330/wjc.v13.i12.654.

本文引用的文献

1
Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.药学服务对慢性恰加斯病所致心力衰竭患者生活质量的影响:随机临床试验。
Br J Clin Pharmacol. 2020 Jan;86(1):143-154. doi: 10.1111/bcp.14152. Epub 2019 Nov 27.
2
Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro.衰老与恰加斯病:里约热内卢巴西城市队列的概述。
Parasit Vectors. 2018 Jun 19;11(1):354. doi: 10.1186/s13071-018-2929-y.
3
Prevalence and factors associated with polypharmacy in the older people: 2006-2014.老年人多药治疗的流行情况及相关因素:2006-2014 年。
J Clin Nurs. 2018 Aug;27(15-16):2942-2952. doi: 10.1111/jocn.14371. Epub 2018 May 28.
4
Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease.苯达唑治疗安全性:无国界医生组织在玻利维亚大量恰加斯病患者中的经验。
J Antimicrob Chemother. 2017 Sep 1;72(9):2596-2601. doi: 10.1093/jac/dkx180.
5
[Brazilian Consensus on Chagas Disease, 2015].[2015年巴西恰加斯病共识]
Epidemiol Serv Saude. 2016 Jun;25(spe):7-86. doi: 10.5123/S1679-49742016000500002.
6
Adverse drug reactions in special populations - the elderly.特殊人群中的药物不良反应——老年人
Br J Clin Pharmacol. 2015 Oct;80(4):796-807. doi: 10.1111/bcp.12596. Epub 2015 May 22.
7
Diagnosis and management of Chagas disease and cardiomyopathy.**诊断和治疗**:恰加斯病和心肌病。
Nat Rev Cardiol. 2012 Oct;9(10):576-89. doi: 10.1038/nrcardio.2012.109. Epub 2012 Jul 31.
8
Safety of benznidazole use in the treatment of chronic Chagas' disease.苯唑达唑治疗慢性恰加斯病的安全性。
J Antimicrob Chemother. 2012 May;67(5):1261-6. doi: 10.1093/jac/dks027. Epub 2012 Feb 13.
9
Chagas disease.恰加斯病。
Lancet. 2010 Apr 17;375(9723):1388-402. doi: 10.1016/S0140-6736(10)60061-X.
10
Pharmacologic therapy of chronic heart failure.慢性心力衰竭的药物治疗
Am J Cardiovasc Drugs. 2007;7(4):235-48. doi: 10.2165/00129784-200707040-00002.